Table 6.
Adverse effects of drugs: percentage of people with symptoms attributable to treatment sufficient to stop taking the tablets, according to category of drug in randomised trials (adapted from Law et al7)
| Category of drug | No of trials | Average dose as multiple of standard | Percentage (95% CI) who stopped taking tablets because of symptoms (treated minus placebo) |
|---|---|---|---|
| Thiazides | 57 | 1.0 | 0.1 (−0.7 to 0.9)* |
| β blockers | 62 | 1.3 | 0.8 (0.3 to 1.4) |
| ACE inhibitors | 92 | 1.9 | 0.1 (−0.3 to 0.6)* |
| Angiotensin II receptor antagonists | 44 | 1.3 | −0.2 (−0.5 to 0.2)* |
| Calcium channel blockers | 92 | 0.5 | −1.3 (−2.6 to 0.0)* |
ACE=angiotensin converting enzyme.
Not statistically significant; however, upper confidence interval is informative.